查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1875832

製药製程用隔膜阀：全球市占率及排名、总收入及需求预测（2025-2031年）

Diaphragm Valves for Pharmaceutical Process - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 132 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球製药製程用隔膜阀市场规模估计为 1.39 亿美元，预计到 2031 年将成长至 2.12 亿美元，2025 年至 2031 年的复合年增长率为 6.5%。

本报告对医药工艺隔膜阀近期关税调整和国际战略应对措施的跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组进行了全面评估。

隔膜阀是一种柔性压力响应元件，它透过传递压力来控制阀门的开启和关闭。弹性体隔膜（一种柔韧耐用的材质）将流体通道与关闭元件隔开。阀内的隔膜起到密封作用，防止流体与阀门的其他工作部件接触，从而避免污染、腐蚀和磨损。

GEMU是全球製药製程隔膜阀领域最重要的主要企业之一，约占全球市场份额的20%。其他主要企业包括Crane Co.（Saunders）、SAMSON（SED Flow Control GmbH）和Burkert Fluid Control Systems。欧洲是最大的市场，约占30%，其次是亚太地区。按材质划分，不銹钢是最大的细分市场，市场占有率超过60%。按应用划分，製药用水系统领域占超过30%的市场。

製药製程用隔膜阀市场驱动因素分析：

1. 遵守政策并提升业界标准

全球药品监管日益收紧

FDA/欧盟GMP要求：无菌药物生产必须符合零洩漏标准，这推动了隔膜阀材质（如PTFE、EPDM）和密封技术的进步。

资料完整性要求：例如，GAMP5 指南要求具备电子阀门记录功能，帮助製药公司获得 FDA 21 CFR 第 11 部分认证。

中国的政策推广

《药品生产监督管理方法》要求对无菌药品生产设备进行定期检验，这导致隔膜瓣膜置换的需求增加。

加强环境保护政策导致对企业采用耐腐蚀、低洩漏隔膜阀的要求越来越高，以降低废水处理成本。

2. 技术创新与产品演进

材料科学的突破

高纯度 PTFE 隔膜的耐热温度提高至 180°C，使其与 SIP/CIP 製程相容，并减少设备停机时间。

金属隔膜阀（例如哈氏合金）用于高腐蚀性介质中，使用寿命可达 10 年以上。

智慧整合

整合感测器可即时监测流量和压力，例如，GEMU 69X 系列支援 IO-Link通讯协定，提高了製程控制精度。

自动原位清洗 (CIP) 模组和隔膜阀的一体化设计降低了交叉污染的风险。

小型化和模组化

微型隔膜阀（直径 6 毫米及以下）适用于生物反应器和微流体晶片等新兴应用，有助于加速细胞治疗药物的生产。

模组化设计可快速更换阀芯，进而减少设备维护时间。

三、全球製药业的扩张

生物製药生产能力的去中心化

预计到 2028 年，全球生物製药市场规模将达到 5,600 亿美元。单株抗体和抗体药物偶联物 (ADC) 的生产需要高纯度隔膜阀来控制培养基和缓衝溶液。

中国生物製药公司（如百济神州和恆瑞药业）正在加速工厂建设，推动了当地对隔膜阀的需求成长。

CDMO产业的崛起

全球排名前 10 的 CDMO 公司（如 Lonza 和 Catalent）正在扩大其生产能力，并引领标准化隔膜阀的采购规模。

模组化工厂（例如 GE Healthcare 的 KUBio）使用预装隔膜阀系统来缩短计划交付时间。

新兴市场的采用情况

印度和东南亚学名药生产的扩张正在推动对经济实惠的隔膜瓣膜的需求。

製药製程隔膜阀市场的成长主要受政策合规、技术创新、产业扩张和供应链重组的驱动。为了在生物製药和合约研发生产（CDMO）等高成长细分市场占有一席之地，同时应对成本压力和技术壁垒，企业需要专注于高端材料研发、智慧整合和全球扩张，以巩固其市场地位。

本报告旨在对全球製药工艺隔膜阀市场按地区/国家、类型和应用进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以2024年为基准年，对製药工艺隔膜阀市场规模、估计值和预测进行了阐述，单位为销售（千台）和收入（百万美元），涵盖2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定製药製程隔膜阀的业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • GEMU
  • Crane Co.（Saunders）
  • SAMSON（SED Flow Control Gmbh）
  • Burkert Fluid Control Systems
  • INOXPA SAU
  • Aquasyn
  • Alfa Laval
  • ITT
  • NDV
  • Hylok
  • Swagelok
  • Parker Hannifin
  • Watson-Marlow Fluid Technology Group（ASEPCO）
  • Steel & O'Brien
  • Shanghai REMY
  • Rodaff Fluid Tech

按类型分類的细分市场

  • 不銹钢
  • 塑胶
  • 其他的

应用领域

  • 製药用水系统
  • CIP 和 SIP 系统
  • 过滤和填充
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Diaphragm Valves for Pharmaceutical Process was estimated to be worth US$ 139 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Diaphragm Valves for Pharmaceutical Process cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

A Diaphragm valve is a flexible, pressure responsive element that transmits force to throttle, open or close a valve. Diaphragm valves separate the flow stream from the closure element using an elastomeric diaphragm, which is a flexible, durable material. The diaphragm in a valve serves as a seal to prevent the liquid encountering other operating parts of the valve, avoiding contamination, corrosion and wear.

GEMU is one of the most important global key players of the diaphragm valves for pharmaceutical process, holds about 20% of shares of global diaphragm valves for pharmaceutical process market, other key players include Crane Co. (Saunders), SAMSON (SED Flow Control Gmbh), Burkert Fluid Control Systems, etc. Europe is the largest market, occupied for about 30 percent, followed by the Asia Pacific. In terms of materials, stainless steel is the largest segment, with a share of over 60%, and in terms of application, the pharmaceutical water system segment holds a share of over 30 percent.

Analysis of market drivers of diaphragm valves for pharmaceutical processes:

1. Policy compliance and industry standard upgrades

Global drug regulation is becoming stricter

FDA/EU GMP requirements: Aseptic preparation production must meet zero leakage standards, which promotes the upgrade of diaphragm valve materials (such as PTFE, EPDM) and sealing technology.

Data integrity specifications: For example, the GAMP5 guideline requires valves to have electronic recording functions, which supports pharmaceutical companies to pass FDA 21 CFR Part 11 certification.

China's policy promotion

The "Drug Production Supervision and Management Measures" requires regular verification of sterile drug production equipment, driving the demand for diaphragm valve replacement.

Tightening environmental protection policies have forced companies to adopt corrosion-resistant, low-leakage diaphragm valves to reduce waste liquid treatment costs.

2. Technological innovation and product iteration

Breakthrough in material science

The temperature tolerance of high-purity PTFE diaphragms has been increased to 180°C, which is compatible with SIP/CIP processes and reduces equipment downtime.

Metal diaphragm valves (such as Hastelloy) are used in highly corrosive media to extend their service life to more than 10 years.

Intelligent integration

Integrated sensors enable real-time monitoring of flow and pressure. For example, the GEMU 69X series supports the IO-Link protocol to improve process control accuracy.

Automated cleaning module (CIP) and diaphragm valve integrated design reduce cross-contamination risk.

Miniaturization and modularization

Micro diaphragm valves (diameter ≤ 6mm) are suitable for emerging scenarios such as bioreactors and microfluidic chips to promote the production of cell therapy drugs.

Modular design supports rapid replacement of valve cores and shortens equipment maintenance time.

III. Global pharmaceutical industry expansion

Breaking up of biopharmaceutical production capacity

The global biopharmaceutical market size is expected to reach US$560 billion in 2028. The production of monoclonal antibodies and ADC drugs requires high-purity diaphragm valves to control culture media/buffers.

Chinese biopharmaceutical companies (such as BeiGene and Hengrui Medicine) are accelerating factory construction, driving the growth of local diaphragm valve demand.

The rise of the CDMO industry

The global TOP10 CDMO companies (such as Lonza and Catalent) have expanded their production capacity, driving the scale of standardized diaphragm valve procurement.

Modular factories (such as GE Healthcare's KUBio) use pre-installed diaphragm valve systems to shorten project delivery cycles.

Penetration in emerging markets

The growth of generic drug production in India and Southeast Asia has driven the demand for cost-effective diaphragm valves.

The growth of the diaphragm valve market for pharmaceutical processes is driven by policy compliance, technological innovation, industrial expansion and supply chain reconstruction. In the future, companies need to focus on high-end material research and development, intelligent integration and global layout, while grasping high-growth tracks such as biopharmaceuticals and CDMO to cope with cost pressures and technical barriers and consolidate their market position.

This report aims to provide a comprehensive presentation of the global market for Diaphragm Valves for Pharmaceutical Process, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diaphragm Valves for Pharmaceutical Process by region & country, by Type, and by Application.

The Diaphragm Valves for Pharmaceutical Process market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diaphragm Valves for Pharmaceutical Process.

Market Segmentation

By Company

  • GEMU
  • Crane Co.(Saunders)
  • SAMSON (SED Flow Control Gmbh)
  • Burkert Fluid Control Systems
  • INOXPA SAU
  • Aquasyn
  • Alfa Laval
  • ITT
  • NDV
  • Hylok
  • Swagelok
  • Parker Hannifin
  • Watson-Marlow Fluid Technology Group (ASEPCO)
  • Steel & O'Brien
  • Shanghai REMY
  • Rodaff Fluid Tech

Segment by Type

  • Stainless Steel
  • Plastic
  • Others

Segment by Application

  • Pharmaceutical Water System
  • CIP and SIP System
  • Filtration and Filling
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Diaphragm Valves for Pharmaceutical Process manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Diaphragm Valves for Pharmaceutical Process in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Diaphragm Valves for Pharmaceutical Process in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Diaphragm Valves for Pharmaceutical Process Product Introduction
  • 1.2 Global Diaphragm Valves for Pharmaceutical Process Market Size Forecast
    • 1.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value (2020-2031)
    • 1.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume (2020-2031)
    • 1.2.3 Global Diaphragm Valves for Pharmaceutical Process Sales Price (2020-2031)
  • 1.3 Diaphragm Valves for Pharmaceutical Process Market Trends & Drivers
    • 1.3.1 Diaphragm Valves for Pharmaceutical Process Industry Trends
    • 1.3.2 Diaphragm Valves for Pharmaceutical Process Market Drivers & Opportunity
    • 1.3.3 Diaphragm Valves for Pharmaceutical Process Market Challenges
    • 1.3.4 Diaphragm Valves for Pharmaceutical Process Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Diaphragm Valves for Pharmaceutical Process Players Revenue Ranking (2024)
  • 2.2 Global Diaphragm Valves for Pharmaceutical Process Revenue by Company (2020-2025)
  • 2.3 Global Diaphragm Valves for Pharmaceutical Process Players Sales Volume Ranking (2024)
  • 2.4 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Company Players (2020-2025)
  • 2.5 Global Diaphragm Valves for Pharmaceutical Process Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Diaphragm Valves for Pharmaceutical Process Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Diaphragm Valves for Pharmaceutical Process Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Diaphragm Valves for Pharmaceutical Process
  • 2.9 Diaphragm Valves for Pharmaceutical Process Market Competitive Analysis
    • 2.9.1 Diaphragm Valves for Pharmaceutical Process Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Diaphragm Valves for Pharmaceutical Process Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diaphragm Valves for Pharmaceutical Process as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Stainless Steel
    • 3.1.2 Plastic
    • 3.1.3 Others
  • 3.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Type
    • 3.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value, by Type (2020-2031)
    • 3.2.3 Global Diaphragm Valves for Pharmaceutical Process Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Type
    • 3.3.1 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Diaphragm Valves for Pharmaceutical Process Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pharmaceutical Water System
    • 4.1.2 CIP and SIP System
    • 4.1.3 Filtration and Filling
    • 4.1.4 Others
  • 4.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Application
    • 4.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value, by Application (2020-2031)
    • 4.2.3 Global Diaphragm Valves for Pharmaceutical Process Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Application
    • 4.3.1 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Diaphragm Valves for Pharmaceutical Process Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region
    • 5.1.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (2020-2025)
    • 5.1.3 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (2026-2031)
    • 5.1.4 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (%), (2020-2031)
  • 5.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region
    • 5.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (2020-2025)
    • 5.2.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (2026-2031)
    • 5.2.4 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Diaphragm Valves for Pharmaceutical Process Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 5.4.2 North America Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 5.5.2 Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Diaphragm Valves for Pharmaceutical Process Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 5.7.2 South America Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 6.3.2 United States Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 6.4.2 Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 6.5.2 China Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 6.6.2 Japan Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 6.7.2 South Korea Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
    • 6.9.2 India Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 GEMU
    • 7.1.1 GEMU Company Information
    • 7.1.2 GEMU Introduction and Business Overview
    • 7.1.3 GEMU Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 GEMU Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.1.5 GEMU Recent Development
  • 7.2 Crane Co.(Saunders)
    • 7.2.1 Crane Co.(Saunders) Company Information
    • 7.2.2 Crane Co.(Saunders) Introduction and Business Overview
    • 7.2.3 Crane Co.(Saunders) Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Crane Co.(Saunders) Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.2.5 Crane Co.(Saunders) Recent Development
  • 7.3 SAMSON (SED Flow Control Gmbh)
    • 7.3.1 SAMSON (SED Flow Control Gmbh) Company Information
    • 7.3.2 SAMSON (SED Flow Control Gmbh) Introduction and Business Overview
    • 7.3.3 SAMSON (SED Flow Control Gmbh) Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 SAMSON (SED Flow Control Gmbh) Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.3.5 SAMSON (SED Flow Control Gmbh) Recent Development
  • 7.4 Burkert Fluid Control Systems
    • 7.4.1 Burkert Fluid Control Systems Company Information
    • 7.4.2 Burkert Fluid Control Systems Introduction and Business Overview
    • 7.4.3 Burkert Fluid Control Systems Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Burkert Fluid Control Systems Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.4.5 Burkert Fluid Control Systems Recent Development
  • 7.5 INOXPA SAU
    • 7.5.1 INOXPA SAU Company Information
    • 7.5.2 INOXPA SAU Introduction and Business Overview
    • 7.5.3 INOXPA SAU Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 INOXPA SAU Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.5.5 INOXPA SAU Recent Development
  • 7.6 Aquasyn
    • 7.6.1 Aquasyn Company Information
    • 7.6.2 Aquasyn Introduction and Business Overview
    • 7.6.3 Aquasyn Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Aquasyn Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.6.5 Aquasyn Recent Development
  • 7.7 Alfa Laval
    • 7.7.1 Alfa Laval Company Information
    • 7.7.2 Alfa Laval Introduction and Business Overview
    • 7.7.3 Alfa Laval Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Alfa Laval Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.7.5 Alfa Laval Recent Development
  • 7.8 ITT
    • 7.8.1 ITT Company Information
    • 7.8.2 ITT Introduction and Business Overview
    • 7.8.3 ITT Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 ITT Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.8.5 ITT Recent Development
  • 7.9 NDV
    • 7.9.1 NDV Company Information
    • 7.9.2 NDV Introduction and Business Overview
    • 7.9.3 NDV Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 NDV Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.9.5 NDV Recent Development
  • 7.10 Hylok
    • 7.10.1 Hylok Company Information
    • 7.10.2 Hylok Introduction and Business Overview
    • 7.10.3 Hylok Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Hylok Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.10.5 Hylok Recent Development
  • 7.11 Swagelok
    • 7.11.1 Swagelok Company Information
    • 7.11.2 Swagelok Introduction and Business Overview
    • 7.11.3 Swagelok Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Swagelok Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.11.5 Swagelok Recent Development
  • 7.12 Parker Hannifin
    • 7.12.1 Parker Hannifin Company Information
    • 7.12.2 Parker Hannifin Introduction and Business Overview
    • 7.12.3 Parker Hannifin Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Parker Hannifin Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.12.5 Parker Hannifin Recent Development
  • 7.13 Watson-Marlow Fluid Technology Group (ASEPCO)
    • 7.13.1 Watson-Marlow Fluid Technology Group (ASEPCO) Company Information
    • 7.13.2 Watson-Marlow Fluid Technology Group (ASEPCO) Introduction and Business Overview
    • 7.13.3 Watson-Marlow Fluid Technology Group (ASEPCO) Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Watson-Marlow Fluid Technology Group (ASEPCO) Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.13.5 Watson-Marlow Fluid Technology Group (ASEPCO) Recent Development
  • 7.14 Steel & O'Brien
    • 7.14.1 Steel & O'Brien Company Information
    • 7.14.2 Steel & O'Brien Introduction and Business Overview
    • 7.14.3 Steel & O'Brien Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Steel & O'Brien Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.14.5 Steel & O'Brien Recent Development
  • 7.15 Shanghai REMY
    • 7.15.1 Shanghai REMY Company Information
    • 7.15.2 Shanghai REMY Introduction and Business Overview
    • 7.15.3 Shanghai REMY Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Shanghai REMY Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.15.5 Shanghai REMY Recent Development
  • 7.16 Rodaff Fluid Tech
    • 7.16.1 Rodaff Fluid Tech Company Information
    • 7.16.2 Rodaff Fluid Tech Introduction and Business Overview
    • 7.16.3 Rodaff Fluid Tech Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Rodaff Fluid Tech Diaphragm Valves for Pharmaceutical Process Product Offerings
    • 7.16.5 Rodaff Fluid Tech Recent Development

8 Industry Chain Analysis

  • 8.1 Diaphragm Valves for Pharmaceutical Process Industrial Chain
  • 8.2 Diaphragm Valves for Pharmaceutical Process Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Diaphragm Valves for Pharmaceutical Process Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Diaphragm Valves for Pharmaceutical Process Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Diaphragm Valves for Pharmaceutical Process Market Trends
  • Table 2. Diaphragm Valves for Pharmaceutical Process Market Drivers & Opportunity
  • Table 3. Diaphragm Valves for Pharmaceutical Process Market Challenges
  • Table 4. Diaphragm Valves for Pharmaceutical Process Market Restraints
  • Table 5. Global Diaphragm Valves for Pharmaceutical Process Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Diaphragm Valves for Pharmaceutical Process Revenue Market Share by Company (2020-2025)
  • Table 7. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Diaphragm Valves for Pharmaceutical Process Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Diaphragm Valves for Pharmaceutical Process Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Diaphragm Valves for Pharmaceutical Process Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Diaphragm Valves for Pharmaceutical Process Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Diaphragm Valves for Pharmaceutical Process
  • Table 13. Global Diaphragm Valves for Pharmaceutical Process Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diaphragm Valves for Pharmaceutical Process as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Diaphragm Valves for Pharmaceutical Process Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Diaphragm Valves for Pharmaceutical Process Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Diaphragm Valves for Pharmaceutical Process Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Diaphragm Valves for Pharmaceutical Process Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Diaphragm Valves for Pharmaceutical Process Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Diaphragm Valves for Pharmaceutical Process Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Diaphragm Valves for Pharmaceutical Process Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Diaphragm Valves for Pharmaceutical Process Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Diaphragm Valves for Pharmaceutical Process Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Diaphragm Valves for Pharmaceutical Process Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Diaphragm Valves for Pharmaceutical Process Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Diaphragm Valves for Pharmaceutical Process Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Diaphragm Valves for Pharmaceutical Process Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Diaphragm Valves for Pharmaceutical Process Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Volume, (2026-2031) & (K Units)
  • Table 57. GEMU Company Information
  • Table 58. GEMU Introduction and Business Overview
  • Table 59. GEMU Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. GEMU Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 61. GEMU Recent Development
  • Table 62. Crane Co.(Saunders) Company Information
  • Table 63. Crane Co.(Saunders) Introduction and Business Overview
  • Table 64. Crane Co.(Saunders) Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Crane Co.(Saunders) Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 66. Crane Co.(Saunders) Recent Development
  • Table 67. SAMSON (SED Flow Control Gmbh) Company Information
  • Table 68. SAMSON (SED Flow Control Gmbh) Introduction and Business Overview
  • Table 69. SAMSON (SED Flow Control Gmbh) Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. SAMSON (SED Flow Control Gmbh) Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 71. SAMSON (SED Flow Control Gmbh) Recent Development
  • Table 72. Burkert Fluid Control Systems Company Information
  • Table 73. Burkert Fluid Control Systems Introduction and Business Overview
  • Table 74. Burkert Fluid Control Systems Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Burkert Fluid Control Systems Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 76. Burkert Fluid Control Systems Recent Development
  • Table 77. INOXPA SAU Company Information
  • Table 78. INOXPA SAU Introduction and Business Overview
  • Table 79. INOXPA SAU Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. INOXPA SAU Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 81. INOXPA SAU Recent Development
  • Table 82. Aquasyn Company Information
  • Table 83. Aquasyn Introduction and Business Overview
  • Table 84. Aquasyn Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Aquasyn Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 86. Aquasyn Recent Development
  • Table 87. Alfa Laval Company Information
  • Table 88. Alfa Laval Introduction and Business Overview
  • Table 89. Alfa Laval Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Alfa Laval Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 91. Alfa Laval Recent Development
  • Table 92. ITT Company Information
  • Table 93. ITT Introduction and Business Overview
  • Table 94. ITT Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. ITT Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 96. ITT Recent Development
  • Table 97. NDV Company Information
  • Table 98. NDV Introduction and Business Overview
  • Table 99. NDV Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. NDV Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 101. NDV Recent Development
  • Table 102. Hylok Company Information
  • Table 103. Hylok Introduction and Business Overview
  • Table 104. Hylok Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. Hylok Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 106. Hylok Recent Development
  • Table 107. Swagelok Company Information
  • Table 108. Swagelok Introduction and Business Overview
  • Table 109. Swagelok Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. Swagelok Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 111. Swagelok Recent Development
  • Table 112. Parker Hannifin Company Information
  • Table 113. Parker Hannifin Introduction and Business Overview
  • Table 114. Parker Hannifin Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. Parker Hannifin Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 116. Parker Hannifin Recent Development
  • Table 117. Watson-Marlow Fluid Technology Group (ASEPCO) Company Information
  • Table 118. Watson-Marlow Fluid Technology Group (ASEPCO) Introduction and Business Overview
  • Table 119. Watson-Marlow Fluid Technology Group (ASEPCO) Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 120. Watson-Marlow Fluid Technology Group (ASEPCO) Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 121. Watson-Marlow Fluid Technology Group (ASEPCO) Recent Development
  • Table 122. Steel & O'Brien Company Information
  • Table 123. Steel & O'Brien Introduction and Business Overview
  • Table 124. Steel & O'Brien Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 125. Steel & O'Brien Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 126. Steel & O'Brien Recent Development
  • Table 127. Shanghai REMY Company Information
  • Table 128. Shanghai REMY Introduction and Business Overview
  • Table 129. Shanghai REMY Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 130. Shanghai REMY Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 131. Shanghai REMY Recent Development
  • Table 132. Rodaff Fluid Tech Company Information
  • Table 133. Rodaff Fluid Tech Introduction and Business Overview
  • Table 134. Rodaff Fluid Tech Diaphragm Valves for Pharmaceutical Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 135. Rodaff Fluid Tech Diaphragm Valves for Pharmaceutical Process Product Offerings
  • Table 136. Rodaff Fluid Tech Recent Development
  • Table 137. Key Raw Materials Lists
  • Table 138. Raw Materials Key Suppliers Lists
  • Table 139. Diaphragm Valves for Pharmaceutical Process Downstream Customers
  • Table 140. Diaphragm Valves for Pharmaceutical Process Distributors List
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Diaphragm Valves for Pharmaceutical Process Product Picture
  • Figure 2. Global Diaphragm Valves for Pharmaceutical Process Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Diaphragm Valves for Pharmaceutical Process Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Diaphragm Valves for Pharmaceutical Process Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Diaphragm Valves for Pharmaceutical Process Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Diaphragm Valves for Pharmaceutical Process Report Years Considered
  • Figure 7. Global Diaphragm Valves for Pharmaceutical Process Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Diaphragm Valves for Pharmaceutical Process Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Diaphragm Valves for Pharmaceutical Process Revenue in 2024
  • Figure 10. Diaphragm Valves for Pharmaceutical Process Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Stainless Steel Picture
  • Figure 12. Plastic Picture
  • Figure 13. Others Picture
  • Figure 14. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Diaphragm Valves for Pharmaceutical Process Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 17. Global Diaphragm Valves for Pharmaceutical Process Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Diaphragm Valves for Pharmaceutical Process Price by Type (2020-2031) & (US$/Unit)
  • Figure 19. Product Picture of Pharmaceutical Water System
  • Figure 20. Product Picture of CIP and SIP System
  • Figure 21. Product Picture of Filtration and Filling
  • Figure 22. Product Picture of Others
  • Figure 23. Global Diaphragm Valves for Pharmaceutical Process Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 24. Global Diaphragm Valves for Pharmaceutical Process Sales Value Market Share by Application, 2024 & 2031
  • Figure 25. Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 26. Global Diaphragm Valves for Pharmaceutical Process Sales Volume Market Share by Application, 2024 & 2031
  • Figure 27. Global Diaphragm Valves for Pharmaceutical Process Price by Application (2020-2031) & (US$/Unit)
  • Figure 28. North America Diaphragm Valves for Pharmaceutical Process Sales Value (2020-2031) & (US$ Million)
  • Figure 29. North America Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Europe Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Asia Pacific Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Asia Pacific Diaphragm Valves for Pharmaceutical Process Sales Value by Region (%), 2024 VS 2031
  • Figure 34. South America Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. South America Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Middle East & Africa Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Middle East & Africa Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value (%), (2020-2031)
  • Figure 39. Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Volume (%), (2020-2031)
  • Figure 40. United States Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. United States Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • Figure 42. United States Diaphragm Valves for Pharmaceutical Process Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Europe Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Application (%), 2024 VS 2031
  • Figure 46. China Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. China Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • Figure 48. China Diaphragm Valves for Pharmaceutical Process Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Japan Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. Japan Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • Figure 51. Japan Diaphragm Valves for Pharmaceutical Process Sales Value by Application (%), 2024 VS 2031
  • Figure 52. South Korea Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. South Korea Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • Figure 54. South Korea Diaphragm Valves for Pharmaceutical Process Sales Value by Application (%), 2024 VS 2031
  • Figure 55. Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • Figure 57. Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value by Application (%), 2024 VS 2031
  • Figure 58. India Diaphragm Valves for Pharmaceutical Process Sales Value, (2020-2031) & (US$ Million)
  • Figure 59. India Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • Figure 60. India Diaphragm Valves for Pharmaceutical Process Sales Value by Application (%), 2024 VS 2031
  • Figure 61. Diaphragm Valves for Pharmaceutical Process Industrial Chain
  • Figure 62. Diaphragm Valves for Pharmaceutical Process Manufacturing Cost Structure
  • Figure 63. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed